|
|
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Steven Le Gouill
,
Catherine Thieblemont
,
Lucie Oberic
,
Anne Moreau
,
Krimo Bouabdallah
,
et al.
Journal articles
hal-02329536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies
Pierre Sujobert
,
Yannick Le Bris
,
Laurence de Leval
,
Audrey Gros
,
Jean Philippe Merlio
,
et al.
Journal articles
hal-02397399v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party
Johannes Schetelig
,
Patrice Chevallier
,
Michel van Gelder
,
Jennifer Hoek
,
Olivier Hermine
,
et al.
Journal articles
inserm-03549845v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study
Asma Beldi-Ferchiou
,
Jean-Philippe Jais
,
Herve Ghesquieres
,
Rene Olivier Casasnovas
,
Hervé Tilly
,
et al.
British Journal of Haematology, 2023, British Journal of Haematology, 201 (2), pp.256-266. ⟨10.1111/bjh.18642⟩
Journal articles
hal-04224835v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Deep learning FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma
Nicolò Capobianco
,
Michel Meignan
,
Anne-Ségolène Cottereau
,
Laetitia Vercellino
,
Ludovic Sibille
,
et al.
Journal articles
hal-03089357v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma
Sydney Dubois
,
Philippe Ruminy
,
Elodie Bohers
,
Pierre‐julien Viailly
,
Liana Veresezan
,
et al.
Journal articles
hal-03671528v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
Catherine Thieblemont
,
Loic Chartier
,
Ulrich Dührsen
,
Umberto Vitolo
,
Sally Barrington
,
et al.
Journal articles
inserm-03924551v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
Marie-Hélène Delfau-Larue
,
Wolfram Klapper
,
Françoise Berger
,
Fabrice Jardin
,
Josette Brière
,
et al.
Journal articles
hal-02331700v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies
Aurélie Cabannes-Hamy
,
Frédéric Peyrade
,
Fabrice Jardin
,
Jean-François Emile
,
Vincent Delwail
,
et al.
Journal articles
hal-02329451v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA
Roch Houot
,
Carole Soussain
,
Hervé Tilly
,
Corinne Haioun
,
Catherine Thieblemont
,
et al.
Journal articles
hal-01295653v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC
David Beauvais
,
Emmanuel Bachy
,
André Baruchel
,
Jacques-Olivier Bay
,
Denis Caillot
,
et al.
Journal articles
inserm-03349011v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
Maxime Jullien
,
Benoit Tessoulin
,
Hervé Ghesquières
,
Lucie Oberic
,
Franck Morschhauser
,
et al.
Journal articles
inserm-03540506v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
Bertrand Coiffier
,
Catherine Thieblemont
,
Sophie de Guibert
,
Jehan Dupuis
,
Vincent Ribrag
,
et al.
Journal articles
hal-01295660v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study
Fabrice Jardin
,
Jean-Philippe Jais
,
Thierry-Jo Molina
,
Françoise Parmentier
,
Jean-Michel Picquenot
,
et al.
Blood, 2010, 116 (7), pp.1092-1104
Journal articles
ensl-00816038v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up
Jérôme Paillassa
,
Edouard Cornet
,
Stephanie Noel
,
Cécile Tomowiak
,
Aline Schmidt
,
et al.
Journal articles
hal-02416164v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial
Roch Houot
,
Emmanuel Bachy
,
Guillaume Cartron
,
François-Xavier Gros
,
Franck Morschhauser
,
et al.
Journal articles
hal-04212634v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma
Franck Morschhauser
,
Gilles Salles
,
Steven Le Gouill
,
Hervé Tilly
,
Catherine Thieblemont
,
et al.
Journal articles
hal-01928199v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Molecular Classifier Increased the Accuracy of Lymphoma Diagnosis By Expert Pathologists in the Diffuse Large B-Cell Lymphoma Gained Trial from the Lysa
Amine Moslemi
,
Victor Bobée
,
Paul Blanc-Durand
,
Fanny Drieux
,
Fabienne Desmots-Loyer
,
et al.
Journal articles
hal-03770121v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA.
A. Trebouet
,
T. Marchand
,
R. Lemal
,
Emmanuel Gyan
,
Florence Broussais-Guillaumot
,
et al.
Journal articles
inserm-00869892v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
Grégory Lazarian
,
Floriane Theves
,
Myriam Hormi
,
Rémi Letestu
,
Virginie Eclache
,
et al.
Journal articles
hal-03557401v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
Jérôme Paillassa
,
Edouard Cornet
,
Stéphanie Noël
,
Cécile Tomowiak
,
Stéphane Lepretre
,
et al.
Journal articles
inserm-03495791v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia
Edouard Cornet
,
Cécile Tomowiak
,
Aline Tanguy-Schmidt
,
Stéphane Leprêtre
,
Jehan Dupuis
,
et al.
Journal articles
hal-01690636v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria
Jerome Paillassa
,
Roberta Di Blasi
,
Sylvie Chevret
,
Sophie Bernard
,
Michael Darmon
,
et al.
Journal articles
hal-03605011v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French network
Laurence Schenone
,
Caroline Houillier
,
Marie Laure Tanguy
,
Sylvain Choquet
,
Kossi Agbetiafa
,
et al.
Journal articles
hal-03703797v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study
Emmanuel Bachy
,
Roch Houot
,
Pierre Feugier
,
Krimo Bouabdallah
,
Reda Bouabdallah
,
et al.
Journal articles
hal-03679319v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Catherine Thieblemont
,
Hervé Tilly
,
Maria Gomes Da Silva
,
Rene-Olivier Casasnovas
,
Christophe Fruchart
,
et al.
Journal articles
hal-01609346v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
Benoit Tessoulin
,
David Chiron
,
Catherine Thieblemont
,
Lucie Oberic
,
Kamal Bouadballah
,
et al.
Journal articles
hal-03203334v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Steven Le Gouill
,
Asma Beldi-Ferchiou
,
Marion Alcantara
,
Victoria Cacheux
,
Violaine Safar
,
et al.
Journal articles
hal-03012903v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study
Jean-Marie Michot
,
Danielle Canioni
,
Henda Driss
,
Laurent Alric
,
Patrice Cacoub
,
et al.
Journal articles
hal-03213703v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older
Lucie Oberic
,
Frédéric Peyrade
,
Mathieu Puyade
,
Christophe Bonnet
,
Peggy Dartigues-Cuillères
,
et al.
Journal articles
hal-03218435v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|